Document is current
Any future updates will be listed below
-
Authors
Li, Wei
Liu, Bo
Xiang, Xingxing
Zhang, Qun
Yang, Qinglin
Cao, Yinghao
Liu, Tao
-
Funding
Funding for this research was provided by:
The The China Postdoctoral Science Foundation (No. 2023M731216)
Hubei Key Laboratory of Precision Radiation Oncology (No. jzfs008)
Hubei Key Laboratory of Biological Targeted Therapy (No. 2023swbx004)
- License Information
-
More Information
Article History
Received: 3 February 2024
Accepted: 3 April 2025
First Online: 28 April 2025
Declarations
:
: Our study was initiated after receiving approval from the Ethics Committee and Institutional Review Committee of Wuhan Union Hospital (No. 2018-S377). All methods were conducted in accordance with applicable regulations and guidelines. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare no competing interests.
